Reviews To Read – April 3, 2018.
from the Addiction Biology Unit
Quitting smoking is challenging. The recent development of varenicline (Chantix®) for smoking cessation is a successful story. In this article, we review the strong theoretical rationale, major findings in preclinical and clinical studies with varenicline, and post-market surveillance. We also discuss current major challenges and future research directions in medication development for smoking cessation.